Patents

US 9856315 B2: Methylation and acetylation sites

Granted
2018-01-02
Filed
2015-10-15 application 14884327
Type
Utility · 10 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The disclosure features over 5000 methylation and acetylation sites identified in human cell line, human serum and mouse tissues, peptides (including AQUA peptides) comprising a methylation or acetylation site of the disclosure, antibodies specifically bind to a methylation or acetylation site of the disclosure, and diagnostic and therapeutic uses of the above.

Source: PVGPATDIS, file of 2026-04-10 (ipg180102.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
CELL SIGNALING TECHNOLOGY, INC. 49 patentsUS company or organizationDanvers, MAPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Hongbo GuPrinceton, NJ1PVGPATDIS, file of 2026-04-10
Ailan GuoLexington, MA31PVGPATDIS, file of 2026-04-10
Daniel MulhernBeverly, MA3PVGPATDIS, file of 2026-04-10
Jeffrey C. SilvaBeverly, MA1PVGPATDIS, file of 2026-04-10
Jing ZhouBeverly, MA12PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07KPeptidesC07K16/18PVGPATDIS, file of 2026-04-10
G01NInvestigating or analysing materials by determining their chemical or physical propertiesG01N33/543PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.